Category: Actos


In December of 2016, the FDA reaffirmed its warning that Actos (a brand name for pioglitazone) is linked to bladder cancer, particularly for people taking large doses or taking the drug for a year or longer. Actos is commonly prescribed for periods of a year or more to patients suffering